zh-twzhen
zh-twzhen

News-Outstanding Corporate Governance Evaluation Results for the Microbio Group Microbio and Oneness Rank among Top 5% in the Corporate Governance Evaluation for Four Consecutive years; Diamond Biofund Enters Top 5% on Its First Evaluation

2025

Date

Title

2025-02-27

The Board of Directors resolved not to distribute dividends.

>
2025-02-27

The Company’s 2024 consolidated financial statements have been approved by the Board of Directors

>
2025-02-25

Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its Board of Directors resolve not to distribute dividends

>
2025-02-25

Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its BOD resolution to convene the 2025 Annual Shareholders’meeting

>
2025-02-19

Announcement of the date of the Company’s board of directors meeting for the year ended December 31, 2024 Parent Company Only and Consolidated Financial Reports

>
2025-02-17

Oneness Biotech to Present at Healthcare Conference Taipei 2025

>
2025-02-11

News-Oneness Listed in the S&P Global Sustainability Yearbook for the Third Consecutive Year, Ranking Among the Top 10 in the Global “Pharmaceuticals Industry” for 2025

>
2025-02-06

Oneness Biotech Co., LTD receives a China patent on antagonistic LAG-3 aptamers.

>
2025-01-29

Oneness Biotech Co., Ltd., had been granted with MDSAP (Medical Device Single Audit Program) certification for medical device quality management system.

>
2025-01-21

The board of directors of the Company approved a resolution on the 1st issue of the employee stock option certificate of 2025.

>
2025-01-17

Oneness Biotech Co., Ltd. receives a Chinese patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES”on FB825.

>
2025-01-10

Oneness Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

>
2025-01-09

Oneness Nanchou manufacturing site has passed the GMP compliance assessment of foreign pharmaceutical manufacturers reviewed by the DAV

>